Insightec
Develops and distributes the Exablate platform that provides noninvasive treatments for a variety of oncology and gynecology indications.
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor investor investor | €0.0 | round |
| investor investor | €0.0 | round | |
| investor investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor | €0.0 | round | |
| investor investor investor investor investor | €0.0 | round | |
| N/A | €0.0 | round | |
| investor investor investor investor investor investor investor | €0.0 Valuation: €0.0 | round | |
| investor investor investor | €0.0 | round | |
| investor | €0.0 Valuation: €0.0 | round | |
| N/A | €0.0 | round | |
| N/A | €0.0 Valuation: €0.0 | round | |
| investor investor | €0.0 | round | |
* | $150m Valuation: $1.3b | Late VC | |
| Total Funding | 000k | ||
Related Content
Insightec is a medical technology company specializing in the development and commercialization of incisionless focused ultrasound treatments. The company primarily serves patients suffering from neurological and oncological conditions, providing a non-invasive alternative to traditional surgical procedures. Operating in the healthcare and medical device market, Insightec's business model revolves around the sale and licensing of its proprietary Exablate systems to hospitals and medical centers worldwide. Revenue is generated through the initial sale of equipment, ongoing maintenance contracts, and usage-based fees. Insightec's innovative technology aims to improve patient outcomes by reducing recovery times and minimizing surgical risks.
Keywords: focused ultrasound, non-invasive treatment, neurological conditions, oncological conditions, Exablate system, medical technology, patient outcomes, healthcare innovation, surgical alternative, medical devices.